Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Anthrax vaccines: past, present and future.

P C Turnbull1

  • 1Division of Biologics, Public Health Laboratory Service Centre for Applied Microbiology and Research, Salisbury, Wiltshire, UK.

Vaccine
|August 1, 1991
PubMed
Summary
This summary is machine-generated.

Sterne

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction: Muscle health in a mouse model of Duchenne muscular dystrophy can be partially improved by restoring mitochondrial creatine metabolism.

Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme·2020
Same author

Changes in mitochondrial perilipin 3 and perilipin 5 protein content in rat skeletal muscle following endurance training and acute stimulated contraction.

Experimental physiology·2015
Same author

Campylobacter jejuni and salmonella in raw red meats: A Public Health Laboratory Service Survey.

The Journal of hygiene·2010
Same author

Passive transfer of protection against Bacillus anthracis infection in a murine model.

Vaccine·2001
Same author

Definitive identification of Bacillus anthracis--a review.

Journal of applied microbiology·1999
Same author

Human immune responses to the UK human anthrax vaccine.

Journal of applied microbiology·1999
Same journal

Retraction notice to "Effectiveness of prescription-based influenza vaccination services among older adults in Binzhou, China: A cluster-randomized controlled trial" [Vaccine 82 (2026) 128588].

Vaccine·2026
Same journal

Barriers and facilitators to COVID-19 vaccination programme implementation in Ireland: a qualitative study of implementation stakeholders using CFIR.

Vaccine·2026
Same journal

Immunogenicity and safety of a SARS-CoV-2 recombinant vaccine S-268024 booster vaccination versus NVX-CoV2373: Interim results from a phase 3, multicenter, randomized, observer-blind, active-controlled study.

Vaccine·2026
Same journal

Safety and immunogenicity of a reduced, homologous booster dose of the BNT162b2 mRNA COVID-19 vaccine: a single blind, randomized, non-inferiority follow-up trial.

Vaccine·2026
Same journal

Vaccination policies for healthcare personnel in Europe, 2026.

Vaccine·2026
Same journal

A historical overview of the anti-vaccine movement and its public health implications.

Vaccine·2026
See all related articles

Area of Science:

  • Veterinary Medicine
  • Immunology
  • Microbiology

Background:

  • The current anthrax vaccines for livestock and humans are largely based on Sterne's 1937 live spore vaccine (strain 34F2).
  • This vaccine has been effective in controlling anthrax in animals and, consequently, humans.
  • Limitations exist, including contraindications and administration challenges, necessitating improved alternatives.